Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_assertion description "[We have recently designed a novel class of drug, the hybrid peptide, which is chemically synthesized and is composed of a target-binding peptide and a lytic peptide containing cationic-rich amino acid components that disintegrate the cell membrane, leading to cancer cell death via membrane lysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_assertion evidence source_evidence_literature NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_assertion SIO_000772 23358664 NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_assertion wasDerivedFrom befree-20150227 NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_assertion wasGeneratedBy ECO_0000203 NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP463854.RAxWI8AXyIof3MrzG9IZKXtLkOW2GctYU2C4s4_oT4JWE130_provenance.